Your browser doesn't support javascript.
loading
A novel risk score predicts prognosis in melanoma: The combination of three tumor-infiltrating immune cells and four immune-related genes.
Wu, Pin; Cai, Jiaying; Fan, Shengjun; Liu, Qian; Huyan, Tianru; He, Yao; Li, Xuejun; Zhang, Long; Su, Jing; Tie, Lu.
Affiliation
  • Wu P; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing 100191, China.
  • Cai J; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
  • Fan S; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing 100191, China.
  • Liu Q; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing 100191, China.
  • Huyan T; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing 100191, China.
  • He Y; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing 100191, China.
  • Li X; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing 100191, China.
  • Zhang L; Department of Pathology and Department of Interventional Radiology and Vascular Surgery and Wound Healing Center, Peking University Third Hospital, Beijing 100191, China.
  • Su J; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Department of Pathology and Department of Interventional Radiology and Vascular Surgery and Wound Healing Center, Peking University Third Hospital, Beijing 100191, Chin
  • Tie L; Department of Pharmacology and Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing 100191, China. Electronic address: tielu@bjmu.edu.cn.
Clin Immunol ; 228: 108751, 2021 07.
Article in En | MEDLINE | ID: mdl-33974996
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Melanoma Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Melanoma Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: China